Mr Stephen Duerden
Executive Director 16/01/2008
Mr Duerden has over 25 years of experience in investment management, the last 14 of which have been focused on agriculture operations and investments. Stephen was the COO and Director for both the Complex Assets Investments Team and the Singapore operation of Deutsche Bank Asset Management Asia. Prior to this Stephen worked with Deutsche in Australia where he was a member of the Australian Executive Committee responsible for the management of the Australian business, and a member of the Private Equity Investment Committee. Stephen has had exposure to a range of financial products and services during his career. He has been involved in direct property development and management, the listing and administration of REITS, as well as the operation and investment of traditional asset portfolios. He is Member of Risk Committee.
Bcom(Acc.Fin&sys), GDAF&I, FFinSIA,CPA, F FIN Male
Mr Edouard (Ed) Peter
Executive Chairman,Executive Director 22/09/2017
Mr Peter was Head of Deutsche Asset Management Asia Pacific ("DeAM Asia"), Middle East & North Africa. He was also a member of Deutsche Bank's Group Equity Operating Committee and Asset Management Operating Committee. Ed joined Deutsche Bank in 1999 as Head of Equities and Branch Manager of DB Switzerland. In March 2001, Ed moved to Hong Kong with Deutsche Bank and was appointed Head of Global Equities for Asia and Australia, becoming responsible for all of Global Emerging Market Equities in the beginning of 2003. In November 2004, Ed became Head of Asian and Emerging Market Equities for the new Global Markets Division.
Mr Mark Harvey
Non-Executive Deputy Chairman,Non-Executive Director 22/09/2017
Mr Harvey as more than 40 years of experience in agriculture and agribusiness. He started his agribusiness journey managing a 10,000-acre family farm producing seed, grain crops, wool, lamb and beef, from 1976 until 1991. He was one of the founders of Paramount Seeds. While with Elders, Mr Harvey was manager of their national and international seed business from 1996 until 2001. In 2002, he was one of the founding partners of Seed Genetics International. In April 2013, Seed Genetics was sold to S&W Seed Co. Mark was elected as a director at this time. On December 9, 2014 Mr Harvey was elected Chairman of the Board of Directors of S&W Seed Company, a position he still holds. Mr Harvey is a director and shareholder of a company that holds seed and agricultural research production, milling and marketing assets in California, Idaho, Wisconsin and South Australia. He sits on the University of Adelaide, Waite Institute Advisory Board and is involved in various community activities. He is Member of Risk Committee.
Mr Wade Dabinett
Non-Executive Director 22/09/2017
Mr Dabinett has over 14 years of experience in the Australian grain industry, encompassing grain trading, storage, handling and production. Wade is a partner in Longtrail Farms. Wade previously held the position of Chairman of Grain Producers SA for four years after previously serving as Vice Chair for a further two years. He was also the Chair of GPSA's sub-committees for Transport & Supply Chain, Agricultural Security & Priority and was also a member of the Audit & Finance Committee. Wade was previously a member on Primary Producers SA representing the grains industry and a member of the National Policy Council for Grain Producers Australia. He was also appointed in 2015 to the ABC Advisory Committee representing Rural and Regional Australia and reporting to the board on programming and content until 2019. He is Chair of Risk Committee.
Dr Amanda Rischbieth
Non-Executive Director 26/11/2020
Dr Rischbieth has over 35 years' experience in health and academia including CEO and non-executive directorship roles across health care delivery, clinical (critical care), public health, research, ethics, and corporate governance advisory. Amanda is current chairman of the National Blood Authority Australia and a non-executive director of Camp Quality. Following her twelve-month Harvard Advanced Leadership Fellowship in 2017, she was invited back as a Visiting Scientist to join a partnership project between Harvard Chan School of Public Health and Harvard Business School (HBS). She is also an advisory council member of the HBS-led Impact-Weighted Accounts Initiative. She is Member of Risk Committee and Chairman of Environmental, Social and Governance (ESG) Committee.